Nicolas Girerd Selected Research

Cerebral Infarction

1/2021	Identifying patients with cerebral infarction within the time window compatible with reperfusion therapy, diagnostic performance of glutathione S-transferase-π (GST-π) and peroxiredoxin 1 (PRDX1): exploratory prospective multicentre study FLAG-1 protocol.
12/2016	Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Girerd Research Topics

Disease

88	Heart Failure 05/2024 - 04/2010
26	Myocardial Infarction 01/2024 - 11/2013
19	Fibrosis (Cirrhosis) 03/2024 - 01/2018
17	Hypertension (High Blood Pressure) 05/2024 - 04/2011
15	Inflammation (Inflammations) 01/2023 - 07/2012
12	Cardiogenic Shock 05/2024 - 01/2016
10	Atrial Fibrillation 01/2020 - 05/2009
9	Left Ventricular Dysfunction 01/2021 - 12/2017
8	Stroke (Strokes) 12/2023 - 01/2016
6	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2019
6	Hypothermia 03/2024 - 01/2017
5	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 01/2017
5	Chronic Renal Insufficiency 01/2024 - 11/2016
5	Diabetes Mellitus 12/2022 - 01/2014
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 04/2011
4	Respiratory Sounds (Crackle) 03/2024 - 05/2019
4	Coronary Disease (Coronary Heart Disease) 11/2021 - 11/2015
4	Hyperkalemia 04/2021 - 01/2014
3	Heart Arrest (Cardiac Arrest) 05/2024 - 10/2018
3	Ischemia 03/2024 - 12/2016
3	Atherosclerosis 01/2023 - 01/2019
3	Obesity 12/2022 - 01/2020
3	Hemorrhage 02/2022 - 08/2016
3	Sepsis (Septicemia) 02/2022 - 10/2018
3	Thrombosis (Thrombus) 02/2021 - 02/2020
3	Septic Shock (Toxic Shock Syndrome) 01/2021 - 12/2017
3	Hypotension (Low Blood Pressure) 01/2021 - 01/2020
3	Systolic Heart Failure 01/2020 - 01/2014
2	Edema (Dropsy) 03/2024 - 04/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 01/2016
2	ST Elevation Myocardial Infarction 10/2023 - 02/2020
2	Shock 02/2022 - 10/2018
2	COVID-19 09/2021 - 02/2021
2	Hypokalemia 01/2021 - 01/2020
2	Cerebral Infarction 01/2021 - 12/2016
2	Pulmonary Hypertension 01/2021 - 03/2013
2	Proteinuria 10/2020 - 10/2018
2	Poisoning 01/2020 - 10/2019
2	Renal Insufficiency (Renal Failure) 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

36	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2016
22	Spironolactone (Aldactone)FDA LinkGeneric 03/2024 - 06/2016
16	Eplerenone (Inspra)FDA LinkGeneric 01/2024 - 01/2014
14	Mineralocorticoid Receptor AntagonistsIBA 01/2024 - 01/2014
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2012
10	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 04/2011
10	Natriuretic PeptidesIBA 03/2024 - 04/2011
9	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2023 - 01/2014
8	CollagenIBA 05/2024 - 01/2019
8	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 04/2011
7	DiureticsIBA 04/2024 - 02/2017
7	CreatinineIBA 10/2023 - 11/2016
7	SodiumIBA 05/2023 - 06/2016
7	Procollagen Type IIBA 04/2023 - 01/2019
6	AldosteroneIBA 10/2023 - 11/2013
6	procollagen type I carboxy terminal peptide (PICP)IBA 04/2023 - 01/2019
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 01/2016
4	Galectin 3 (LGALS3)IBA 04/2023 - 01/2020
4	Collagen Type I (Type I Collagen)IBA 01/2023 - 01/2021
4	PotassiumIBA 12/2022 - 01/2020
4	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2022 - 01/2019
4	Collagen Type III (Type III Collagen)IBA 01/2022 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2024 - 01/2012
3	Lactic Acid (Lactate)FDA LinkGeneric 03/2024 - 01/2017
3	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2023 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 10/2022
3	Peptides (Polypeptides)IBA 04/2023 - 11/2021
3	AlbuminsIBA 01/2023 - 11/2019
3	Hormones (Hormone)IBA 12/2022 - 04/2011
3	Angiotensin Receptor AntagonistsIBA 06/2021 - 10/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2021 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 11/2020 - 04/2016
3	Uric Acid (Urate)IBA 10/2020 - 11/2015
3	CholesterolIBA 01/2020 - 01/2019
2	Insulin-Like Growth Factor Binding Protein 2IBA 03/2024 - 01/2020
2	Insulin (Novolin)FDA Link 12/2023 - 04/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2019
2	C-Reactive ProteinIBA 01/2022 - 05/2009
2	Growth Differentiation Factor 15IBA 01/2022 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 01/2015
2	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 01/2018
2	PeroxiredoxinsIBA 01/2021 - 12/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2012
2	AdrenomedullinIBA 01/2021 - 01/2019
2	Carvedilol (Coreg)FDA LinkGeneric 01/2020 - 01/2018
2	Valsartan (Vals)FDA Link 01/2020 - 01/2018

Therapy/Procedure

19	Therapeutics 01/2024 - 01/2012
9	Extracorporeal Membrane Oxygenation 05/2024 - 01/2017
5	Kidney Transplantation 10/2023 - 01/2020
4	Length of Stay 01/2022 - 10/2018
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2012 - 05/2009
3	Renal Dialysis (Hemodialysis) 05/2024 - 01/2020
3	Critical Care (Surgical Intensive Care) 10/2023 - 01/2016
3	Transplantation 10/2023 - 03/2013
3	Defibrillators (Defibrillator) 11/2013 - 02/2011
2	Catheters 10/2022 - 02/2020
2	Heart Transplantation (Grafting, Heart) 10/2022 - 10/2019
2	Heart-Assist Devices 02/2022 - 01/2021
2	Resuscitation 01/2021 - 01/2017
2	Prostheses and Implants (Prosthesis) 01/2021 - 03/2012
2	Precision Medicine 01/2020 - 01/2016